News July 19, 2013 Venture capital investments in Maryland soar by 115% in second quarter – baltimoresun.com Venture capitalists invested $318 million in young Maryland companies from April through June, an increase… Super User Love0
News July 19, 2013 Health IT Venture Capital Funding Totals $623M During Q2 – iHealthBeat Venture capital funding for health IT totaled $623 million during the second quarter of 2013,… Super User Love0
News July 18, 2013 Sticking it to big pharma with crowdfunded nanotech Students at the University of York are challenging what they see as the closed worlds… Super User Love0
News July 18, 2013 Crowdfunding For Life Sciences Companies: To Seek Or Not To Seek “We are a team of guerrilla fundraisers who have launched a global campaign to fund… Super User Love0
News July 18, 2013 General George A. Joulwan Joins Emergent BioSolutions Board of Directors Emergent BioSolutions Inc. (NYSE:EBS) today announced the appointment of General George A. Joulwan (retired) to… Super User Love0
News July 18, 2013 Montgomery Business Development Corporation (MBDC) Launches New Business-Friendly Website Montgomery Business Development Corporation is pleased to announce the launch of their new website montgomerybusiness.org.… Super User Love0
News July 18, 2013 Montgomery students enter the lab – Gazette.Net About 20 kids garbed in lab coats, booties and goggles entered a laboratory on Friday… Super User Love0
News July 17, 2013 NeurExpand: Former Martek execs launch brain wellness venture; clinics planned across U.S. – Baltimore Business Journal A group of former executives from Martek Biosciences Corp. have formed a new company that… Super User Love0
News July 17, 2013 After snapping up two Massachusetts companies, Germany’s Qiagen gains a local foothold – Innovation – Boston.com Overseas medical technology companies continue to stream into Greater Boston, lured by the area’s famous… Super User Love0
News July 17, 2013 Rexahn Pharmaceuticals signs license agreement with UMB for novel drug delivery platform Rexahn Pharmaceuticals, Inc. (NYSE MKT: RNN), a clinical stage biopharmaceutical company, announced today that it… Super User Love0